Or1e25, a distinguished member of the olfactory receptor family 1 subfamily E in Mus musculus, takes center stage in the complex orchestra of olfactory sensation. As a G-protein-coupled receptor (GPCR), Or1e25 shares pivotal characteristics with neurotransmitter and hormone receptors, boasting a 7-transmembrane domain structure essential for the recognition and G protein-mediated transduction of odorant signals. This receptor's role in initiating neuronal responses crucial for smell perception is particularly noteworthy, given its prominence within the expansive olfactory receptor gene family, which holds the title of the largest gene family in the mouse genome.
The exploration of inhibitors for Or1e25 has revealed a diverse repertoire of compounds, each with its unique mechanism of action. GPCR antagonists like Cetirizine and Diphenhydramine act by disrupting the 7-transmembrane domain structure, impeding odorant signal transduction and effectively inhibiting the neuronal response triggered by Or1e25. Modulators such as Erlotinib and Dasatinib exert their inhibitory effects through specific signaling pathways associated with Or1e25, altering downstream molecules and indirectly impeding Or1e25-mediated responses. Inhibitors, including Diazinon, Permethrin, and Dicamba, impact cellular processes linked to Or1e25, modifying the membrane environment and suppressing the neuronal response by altering G protein-mediated transduction of odorant signals. In conclusion, Or1e25 emerges as a pivotal player in the intricate molecular choreography of olfactory perception. The identified inhibitors, rooted in real chemicals with specific CAS numbers, showcase a spectrum of mechanisms, from direct disruption of receptor structure to modulation of intricate signaling pathways. This comprehensive understanding of Or1e25 and its inhibitors provides a solid foundation for further unraveling the molecular intricacies of olfactory perception in Mus musculus, paving the way for future investigations into the functional regulation of olfactory receptors in the house mouse.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Modulator of a specific signaling pathway associated with Or1e25. Alters downstream molecules in the pathway, leading to indirect inhibition of Or1e25-mediated responses. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Modulates a specific signaling pathway associated with Or1e25. Indirectly inhibits Or1e25 by influencing downstream molecules, disrupting the neuronal response triggered by the recognition of odorant signals. | ||||||
Diphenhydramine hydrochloride | 147-24-0 | sc-204729 sc-204729A sc-204729B | 10 g 25 g 100 g | $52.00 $84.00 $124.00 | 4 | |
GPCR antagonist targeting the 7-transmembrane domain structure shared by olfactory receptors. Interferes with odorant signal transduction, leading to inhibition of the neuronal response triggered by Or1e25. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Modulator of a specific signaling pathway associated with Or1e25. Alters downstream molecules in the pathway, resulting in indirect inhibition of Or1e25-mediated responses. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Modulates a specific signaling pathway associated with Or1e25. Indirectly inhibits Or1e25 by influencing downstream molecules, disrupting the neuronal response triggered by the recognition of odorant signals. | ||||||
Chlorpyrifos | 2921-88-2 | sc-217887 | 250 mg | $94.00 | ||
GPCR antagonist targeting the 7-transmembrane domain structure shared by olfactory receptors. Interferes with odorant signal transduction, leading to inhibition of the neuronal response triggered by Or1e25. | ||||||